Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01024608 · ClinicalTrials.gov registry record · Phase 3
Study in Adult and Adolescent Subjects With Seasonal Allergic Rhinitis (SAR)
A Phase 3 study, sponsored by Teva Branded Pharmaceutical Products R&D.
- Completed
- Registry status
- Phase 3
- Development phase
- 340
- Enrollment target
NCT01024608 is a Phase 3 study that has completed, run by Teva Branded Pharmaceutical Products R&D. The registered enrollment target is 340 participants.
The verdict
NCT01024608, a Phase 3 study, has completed, sponsored by Teva Branded Pharmaceutical Products R&D.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 340 participants
- Enrollment target
Study Summary
The purpose of the study is to assess the efficacy and safety of an investigational nasal aerosol compared with placebo nasal aerosol in the treatment of seasonal allergic rhinitis.
Interventions
- DRUG Beclomethasone dipropionate
- DRUG Placebo Nasal Aerosol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 340 participants |
| Start Date | 2009-12-31 |
| Est. Completion | 2010-02-28 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01024608
The ClinicalTrials.gov registry entry for NCT01024608 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 340 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Teva Branded Pharmaceutical Products R&D, which has 167 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Beclomethasone dipropionate is the first listed.
NCT01024608 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01024608 about?
NCT01024608 is a clinical study titled "Study in Adult and Adolescent Subjects With Seasonal Allergic Rhinitis (SAR)". The purpose of the study is to assess the efficacy and safety of an investigational nasal aerosol compared with placebo nasal aerosol in the treatment of seasonal allergic rhinitis.
What is the current status of trial NCT01024608?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 340 participants. The study started on 2009-12-31. Estimated completion is 2010-02-28.
What interventions are being tested in trial NCT01024608?
The interventions under investigation include: Beclomethasone dipropionate (DRUG), Placebo Nasal Aerosol (DRUG).
Who is sponsoring clinical trial NCT01024608?
This trial is sponsored by Teva Branded Pharmaceutical Products R&D, which has 167 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.